Understanding peanut and tree nut allergies and improving diagnostics and treatments
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
['FUNDING_R01'] · UNIVERSITY OF COLORADO DENVER · NIH-10912750
This study is looking at how our immune system reacts to peanuts and tree nuts, which can cause allergies in many kids and adults, to find better ways to diagnose and treat these allergies by understanding the proteins that trigger reactions.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF COLORADO DENVER (nih funded) |
| Locations | 1 site (Aurora, UNITED STATES) |
| Trial ID | NIH-10912750 on ClinicalTrials.gov |
What this research studies
This research focuses on the immune responses involved in peanut and tree nut allergies, which affect many children and adults. It aims to explore the specific proteins (2S albumins) that trigger allergic reactions and to develop better diagnostic tools and treatment strategies. By studying the molecular interactions between these allergens and the immune system, the research seeks to identify critical components that could lead to more effective therapies. The approach includes advanced techniques to analyze the structure of allergens and their binding to immune cells.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals of all ages who have been diagnosed with peanut or tree nut allergies.
Not a fit: Patients who do not have allergies to peanuts or tree nuts are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostics and more effective treatments for peanut and tree nut allergies, enhancing the quality of life for affected individuals.
How similar studies have performed: Previous research has shown promise in understanding food allergies and developing immunotherapies, indicating that this approach could lead to significant advancements.
Where this research is happening
Aurora, UNITED STATES
- UNIVERSITY OF COLORADO DENVER — Aurora, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DRESKIN, STEPHEN C — UNIVERSITY OF COLORADO DENVER
- Study coordinator: DRESKIN, STEPHEN C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.